Table 2.
Cohort characteristics of 502 cases included for analysis
| Adult (n = 279) | Paediatric (n = 223) | Combined (n = 502) | ||||
|---|---|---|---|---|---|---|
| Freq | % | Freq | % | Freq | % | |
| Region | ||||||
| Scandinavia | 148 | 53.0 | 38 | 17.0 | 186 | 37.1 |
| Netherlands | 131 | 47.0 | 185 | 83.0 | 316 | 62.9 |
| Gender | ||||||
| M | 150 | 53.8 | 129 | 57.8 | 279 | 55.6 |
| F | 129 | 46.2 | 94 | 42.2 | 223 | 44.4 |
| Disease stage | ||||||
| Initial | 241 | 86.4 | 202 | 90.6 | 443 | 88.2 |
| Recurrent | 37 | 13.3 | 21 | 9.4 | 58 | 11.6 |
| Metastasis | 1 | 0.4 | 0 | 0 | 1 | 0.2 |
| Reason to perform MP | ||||||
| Routine/gain experience with tool | 194 | 69.5 | 144 | 64.6 | 338 | 67.3 |
| Challenging diagnosis | 60 | 21.5 | 29 | 13.0 | 89 | 17.7 |
| Subclassification | 3 | 1.1 | 40 | 17.9 | 43 | 8.6 |
| Revision/re‐evaluation | 22 | 7.9 | 10 | 4.5 | 32 | 6.4 |
| Mean | SD | Mean | SD | |||
| Age | 50.83 | 16.917 | 8.69 | 5.545 | ||
Freq, frequency; SD, standard deviation.